Laboratory News and Research

RSS

FDA warns consumers about potential health risks of two natural dietary supplements

The U.S. Food and Drug Administration today issued a new warning to consumers about the potential health risks of two products marketed as natural dietary supplements for treating arthritis, muscle pain, osteoporosis, bone cancer, and other conditions.

22 Aug 2012

ICUS applauds FDA's decision to modify U.S. product label for OPTISON ultrasound contrast agent

The International Contrast Ultrasound Society (ICUS) today applauded the FDA's decision to modify the U.S. product label for OPTISON, an ultrasound contrast agent used to improve the accuracy of radiation-free ultrasound scans.

22 Aug 2012

VolitionRX to initiate NuQ blood-based tests in colorectal cancer clinical trial

VolitionRX Limited, a life sciences company focused on developing blood-based diagnostic tests, announces that its subsidiary Belgian Volition has signed an agreement with the Biobank of CHU UCL Mont-Godinne, an academic hospital in Yvoir, Belgium.

22 Aug 2012

Healthcare announces important changes to the U.S. product label for Optison

GE Healthcare today announced important changes to the U.S. product label for Optison (Perflutren Protein-Type A Microspheres Injectable Suspension, USP), a contrast agent that may improve the visualization of the left ventricular border - an area of the heart that is critical to see in order to diagnose certain heart diseases such as hypertrophic cardiomyopathy.

22 Aug 2012

New silicon chips help identify patients with lupus

Researchers at the Stanford University School of Medicine and Intel Corp. have collaborated to synthesize and study a grid-like array of short pieces of a disease-associated protein on silicon chips normally used in computer microprocessors.

21 Aug 2012

Study identifies mode of death of cone photoreceptor cells in animal model of RP

Research conducted at the Angiogenesis Laboratory at Massachusetts Eye and Ear Infirmary, has for the first time, identified the mode of death of cone photoreceptor cells in an animal model of retinitis pigmentosa (RP).

21 Aug 2012

Study shows significant benefits of temporal training on cognitive function in the elderly

Research has found that declines in temporal information processing (TIP), the rate at which auditory information is processed, underlies the progressive loss of function across multiple cognitive systems in the elderly, including new learning, memory, perception, attention, thinking, motor control, problem solving, and concept formation. In a new study, scientists have found that elderly subjects who underwent temporal training improved not only the rate at which they processed auditory information, but also in other cognitive areas.

21 Aug 2012

New neurotechnology aims to help rehabilitate stroke survivors

What comes naturally to most people - to think and then do - is difficult for stroke patients who have lost the full use of their limbs. New research by Rice University, the University of Houston (UH) and TIRR Memorial Hermann aims to help victims recover that ability to the fullest extent possible with a $1.17 million grant from the National Institutes of Health (NIH) and the President's National Robotics Initiative (NRI).

21 Aug 2012

Researchers reveal possible drug targets to combat anthrax

A trawl of the genome of the deadly bacterium Bacillus anthracis has revealed a clutch of targets for new drugs to combat an epidemic of anthrax or a biological weapons attack.

21 Aug 2012

Injectable controlled-release capsules against gum disease

Scientists are trying to open a new front in the battle against gum disease, the leading cause of tooth loss in adults and sometimes termed the most serious oral health problem of the 21st century. They described another treatment approach for the condition in a report here today at the 244th National Meeting & Exposition of the American Chemical Society, the world's largest scientific society.

20 Aug 2012

Cervical cancer screening: an interview with Alastair Atkinson, CEO of DySIS Medical Ltd

Cervical Cancer is a tragic disease. First and foremost, because it is entirely preventable if the early symptoms are detected in a timely manner

20 Aug 2012

Resveratrol might help improve mobility and prevent life-threatening falls among older people

In a stride toward better health in later life, scientists reported today that resveratrol, the so-called "miracle molecule" found in red wine, might help improve mobility and prevent life-threatening falls among older people.

20 Aug 2012

Study demonstrates how Elesclomol blocks oxidative phosphorylation in melanoma

A laboratory study led by UNC medical oncologist Stergios Moschos, MD, demonstrates how a new targeted drug, Elesclomol, blocks oxidative phosphorylation, which appears to play essential role in melanoma that has not been well-understood. Elesclomol (Synta Pharmaceuticals, Lexington, MA) was previously shown to have clinical benefit only in patients with normal serum lactate dehydrogenase (LDH), a laboratory test routinely used to assess activity of disease.

18 Aug 2012

Two eminent cancer specialists and EORTC to be recognized at ESMO 2012 Congress

The European Society for Medical Oncology (ESMO) announced today the names of two eminent cancer specialists and one European institution that will be recognized for their contribution to the advancement of medical oncology at the ESMO 2012 Congress.

17 Aug 2012

New DNA sequencing tests improve ability to analyze genetic disorders

Scientists at the University of Medicine and Dentistry of New Jersey-New Jersey Medical School (UMDNJ-NJMS) have developed new DNA sequencing tests that hold significant promise for decreasing costs associated with diagnosing cancer and hereditary diseases, including cysticfibrosis.

17 Aug 2012

U-M, IGC launch new joint venture for personalized medicine

As a key step toward providing patients with treatments based on their own DNA profiles, the University of Michigan and the International Genomics Consortium (IGC) have launched a new joint venture that will help usher in an age of personalized medicine.

17 Aug 2012

Nostrum, VCU sign license agreement to develop inhaled dapsone for respiratory diseases

Virginia Commonwealth University and Nostrum Pharmaceuticals, LLC, are pleased to announce the signing of a license agreement for the development of inhaled dapsone for the treatment of respiratory diseases.

17 Aug 2012

U.S. DOE’s Oak Ridge National Laboratory develops new carbon cycling model

A new carbon cycling model developed at the U.S. Department of Energy's (DOE) Oak Ridge National Laboratory better accounts for the carbon dioxide-releasing activity of microbes in the ground, improving scientists' understanding of the role soil will play in future climate change.

17 Aug 2012

Researchers use small molecule compound to generate reversible birth control in male mice

The development of a male contraceptive pill has long proven to be elusive, but findings from a new study may point scientists in the right direction to making oral birth control for men a reality.

17 Aug 2012

Plexin B2-CD100 interaction for prompt activation of γδ T cells and wound healing

Scientists at The Scripps Research Institute have made a breakthrough in understanding a class of cells that help wounds in skin and other epithelial tissues heal, uncovering a molecular mechanism that pushes the body into wound-repair mode.

17 Aug 2012

Laboratory News and Research

FDA warns consumers about potential health risks of two natural dietary supplements

ICUS applauds FDA's decision to modify U.S. product label for OPTISON ultrasound contrast agent

VolitionRX to initiate NuQ blood-based tests in colorectal cancer clinical trial

Healthcare announces important changes to the U.S. product label for Optison

New silicon chips help identify patients with lupus

Study identifies mode of death of cone photoreceptor cells in animal model of RP

Study shows significant benefits of temporal training on cognitive function in the elderly

New neurotechnology aims to help rehabilitate stroke survivors

Researchers reveal possible drug targets to combat anthrax

Injectable controlled-release capsules against gum disease

Cervical cancer screening: an interview with Alastair Atkinson, CEO of DySIS Medical Ltd

Resveratrol might help improve mobility and prevent life-threatening falls among older people

Study demonstrates how Elesclomol blocks oxidative phosphorylation in melanoma

Two eminent cancer specialists and EORTC to be recognized at ESMO 2012 Congress

New DNA sequencing tests improve ability to analyze genetic disorders

U-M, IGC launch new joint venture for personalized medicine

Nostrum, VCU sign license agreement to develop inhaled dapsone for respiratory diseases

U.S. DOE’s Oak Ridge National Laboratory develops new carbon cycling model

Researchers use small molecule compound to generate reversible birth control in male mice

Plexin B2-CD100 interaction for prompt activation of γδ T cells and wound healing

Lab Diagnostics and Automation - Second Edition eBook

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest Life Science News